Searching for just a few words should be enough to get started. If you need to make more complex queries, use the tips below to guide you.
Article type: Research Article
Authors: Dolga, Amalia M.a | Granic, Ivicaa | Nijholt, Ingrid M.a | Nyakas, Csabaa; b | van der Zee, Eddy A.a | Luiten, Paul G.M.a; c | Eisel, Ulrich L.M.a; *
Affiliations: [a] Department of Molecular Neurobiology, Graduate School of Behavioral and Cognitive Neurosciences, University of Groningen, Haren, The Netherlands | [b] Neuropsychopharmacological Research Group of Semmelweis University and Hungarian Academy of Sciences, Budapest, Hungary | [c] Department of Biological Psychiatry, Graduate School of Behavioral and Cognitive Neurosciences, University of Groningen, Haren, The Netherlands
Correspondence: [*] Corresponding author: Ulrich L.M. Eisel, Department of Molecular Neurobiology, Graduate School of Behavioral and Cognitive Neurosciences, University of Groningen, Haren, The Netherlands. Tel.: +31 50 363 2366; Fax: +31 50 363 2331; E-mail: U.L.M.Eisel@rug.nl.
Note: [] Communicated by Angelika Bierhaus
Abstract: Besides a beneficial cardiovascular effect, it was recently suggested that statins can also exert neuroprotective actions. In a previous study, we provided in vitro evidence that lovastatin treatment abates excitotoxic cell death in primary cortical neurons. Here, we investigated the neuroprotective effect of lovastatin in an in vivo mouse model. We found that administration of lovastatin (20 mg/kg) significantly protects cholinergic neurons and their cortical projections against N-methyl-D-aspartate (60 nmol)-induced cell death in the magnocellular nucleus basalis, a neuronal cell group that is characteristically affected in Alzheimer's disease. Furthermore, lovastatin-mediated neuroprotection was shown to be dependent on protein kinase B (PKB)/Akt signaling since treatment with the PKB/Akt inhibitor LY294002 blocked the lovastatin-induced neuroprotective effect. The loss of cholinergic neurons after the lesion in the magnocellular nucleus basalis resulted in memory impairment as tested in a passive avoidance paradigm. This was reverted by pre-lesion lovastatin treatment. From these studies we conclude that treatment with lovastatin may provide protection against neuronal injury in excitotoxic conditions associated with neurodegenerative diseases including Alzheimer's disease.
Keywords: Cholinergic neurons, excitotoxicity, lovastatin, magnocellular nucleus basalis, NMDA, passive avoidance test, PKB/Akt
DOI: 10.3233/JAD-2009-1052
Journal: Journal of Alzheimer's Disease, vol. 17, no. 2, pp. 327-336, 2009
IOS Press, Inc.
6751 Tepper Drive
Clifton, VA 20124
USA
Tel: +1 703 830 6300
Fax: +1 703 830 2300
sales@iospress.com
For editorial issues, like the status of your submitted paper or proposals, write to editorial@iospress.nl
IOS Press
Nieuwe Hemweg 6B
1013 BG Amsterdam
The Netherlands
Tel: +31 20 688 3355
Fax: +31 20 687 0091
info@iospress.nl
For editorial issues, permissions, book requests, submissions and proceedings, contact the Amsterdam office info@iospress.nl
Inspirees International (China Office)
Ciyunsi Beili 207(CapitaLand), Bld 1, 7-901
100025, Beijing
China
Free service line: 400 661 8717
Fax: +86 10 8446 7947
china@iospress.cn
For editorial issues, like the status of your submitted paper or proposals, write to editorial@iospress.nl
如果您在出版方面需要帮助或有任何建, 件至: editorial@iospress.nl